ArticleBMC infectious diseases2025
Genotypic spectrum and prevalence of HPV associated with cervical cancer in Palestine.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Epidemiology of Human Papillomavirus in the Middle East and North Africa: A Review of Genotypic Prevalence, Vaccination Challenges, and Non-Cervical Clinical Outcomes.Diseases (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCervical cancer remains a significant global public health issue, primarily driven by persistent infection with Human Papillomavirus (HPV). Understanding HPV prevalence, genotype distribution, and epidemiological patterns is essential for effective cervical cancer prevention and management.
methodsThis retrospective study analysed 48 paraffin-embedded cervical tissue samples from Palestinian women diagnosed with poorly differentiated squamous cell carcinoma between 2014 and 2024. DNA extraction was successful for 40 cases. HPV detection was conducted via nested PCR targeting the HPV L1 gene, followed by genotype identification using Sanger sequencing.
resultsHPV was detected in 82.5% of samples, predominantly consisting of high-risk HPV types (77.5%), with HPV16 (32.5%) and HPV18 (10%) being the most prevalent. Women aged 50–59 years exhibited the highest HPV positivity rate. The geographical distribution showed distinct regional variations, particularly clusters of HPV16 infections in specific Palestinian regions.
conclusionsThe high prevalence of HPV, particularly high-risk genotypes such as HPV16 and HPV18, underscores the urgent need for nationwide HPV vaccination and standardized cervical cancer screening programs in Palestine. These findings provide critical epidemiological insights necessary to inform and optimize local public health strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.